The differences between batch processing and continuous manufacturing of biologics require a detailed understanding of material traceability and the effects of perturbations on material quality.
The benefits of continuous biologics manufacturing are generally accepted, but transitioning to continuous processing from batch processing is hindered by the lack of modeling and simulation tools.
MIT introduces Self-Distillation Fine-Tuning to reduce catastrophic forgetting; it uses student-teacher demonstrations and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results